英夫利昔单抗谷浓度可能预测强直性脊柱炎患者英夫利昔单抗的长期维持效果。 - Suppr

Suppr

超能文献

Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis.

作者信息

Chu Miow Lin D, Mulleman D, Azzopardi N, Griffoul-Espitalier I, Valat J-P, Paintaud G, Goupille P

出版信息

Scand J Rheumatol. 2010;39(1):97-8. doi: 10.3109/03009740903177745.

DOI:10.3109/03009740903177745

PMID:20132079

Abstract

摘要

相似文献

Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis.

Scand J Rheumatol. 2010;39(1):97-8. doi: 10.3109/03009740903177745.

Low-dose infliximab treatment for ankylosing spondylitis--clinically- and cost-effective.

Rheumatology (Oxford). 2006 Dec;45(12):1566-9. doi: 10.1093/rheumatology/kel156. Epub 2006 May 16.

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.

Rheumatology (Oxford). 2006 Jul;45(7):859-62. doi: 10.1093/rheumatology/kel015. Epub 2006 Jan 25.

Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.

Arthritis Rheum. 2006 Oct 15;55(5):812-6. doi: 10.1002/art.22236.

Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study.

Arthritis Rheum. 2009 May 15;61(5):569-76. doi: 10.1002/art.24275.

Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.

Scand J Rheumatol. 2004;33(5):323-6. doi: 10.1080/03009740310004720.

Infliximab in severe active ankylosing spondylitis with spinal ankylosis.

Intern Med J. 2008 Jun;38(6):396-401. doi: 10.1111/j.1445-5994.2007.01599.x. Epub 2008 Mar 7.

Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.

Ann Rheum Dis. 2008 Mar;67(3):340-5. doi: 10.1136/ard.2007.075879. Epub 2007 Oct 29.

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.

Ann Rheum Dis. 2005 May;64(5):704-7. doi: 10.1136/ard.2004.030452. Epub 2004 Oct 14.

Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.

Ann Rheum Dis. 2008 Dec;67(12):1697-701. doi: 10.1136/ard.2007.083683. Epub 2008 Jan 31.

引用本文的文献

External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab.

Pharmaceutics. 2021 Aug 3;13(8):1191. doi: 10.3390/pharmaceutics13081191.

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial.

RMD Open. 2020 Jan;6(1). doi: 10.1136/rmdopen-2019-001047. Epub 2020 Jan 9.

Therapeutic drug monitoring of infliximab in spondyloarthritis. A review of the literature.

Br J Clin Pharmacol. 2019 Oct;85(10):2264-2279. doi: 10.1111/bcp.14062. Epub 2019 Aug 6.

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases.

Arthritis Res Ther. 2011 Jun 27;13(3):R105. doi: 10.1186/ar3386.

Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.

Br J Clin Pharmacol. 2012 Jan;73(1):55-65. doi: 10.1111/j.1365-2125.2011.04050.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验